15W118: Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science II (2575–2580)

Presenting Author(s)

• 

  Rohit Aggarwal, MD, MS

  University of Pittsburgh
  Pittsburgh, PA, United States

  Disclosure(s): Actigraph: Consultant (Ongoing); Alexion: Consultant (Ongoing); ANI Pharmaceuticals: Consultant (Ongoing); Argenx: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing), Grant/Research Support (Ongoing); CabalettaBio: Consultant (Ongoing); Capella Bioscience: Consultant (Ongoing); Corbus: Consultant (Ongoing); CSL Behring: Consultant (Ongoing); EMD Serono: Consultant (Ongoing), Grant/Research Support (Ongoing); Galapagos: Consultant (Ongoing); Horizon Therapeutics: Consultant (Ongoing); I-Cell: Consultant (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Kezar: Consultant (Ongoing); Kyverna: Consultant (Ongoing); Mallinckrodt: Grant/Research Support (Ongoing); Merck: Consultant (Ongoing); Octapharma: Consultant (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); Q32: Grant/Research Support (Ongoing); Roivant: Consultant (Ongoing); Sanofi: Consultant (Ongoing); Teva: Consultant (Ongoing)
• AA

  Astia Allenzara, MD

  UNC
  Chapel Hill, NC, United States

  Disclosure information not submitted.
• EA

  Emma Austenfeld, MD, MPH

  Medical College of Wisconsin
  Whitefish Bay, WI, United States

  Disclosure information not submitted.
• KJ

  Kasper Yde Jensen, MSc

  Copenhagen University Hospital - Rigshospitalet
  Copenhagen, Denmark

  Disclosure information not submitted.
• 

  Alexander Oldroyd, PhD, MSc, MBChB, MRCP

  University of Manchester
  Manchester, United Kingdom

  Disclosure information not submitted.
• JW

  Jing Yi Wei, BS, MSc

  University of Toronto
  Calgary, AB, Canada

  Disclosure information not submitted.

Abstract oral session.

Non-CME

Presentations:

• 9:15 AM – 9:25 AM PT

  Accurate Stratification of Cancer Risk in a Real-World Cohort Using the International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening
  

  Presenting Author: Alexander Oldroyd, PhD, MSc, MBChB, MRCP – University of Manchester
• 9:25 AM – 9:30 AM PT

  Q&A
  
• 9:30 AM – 9:40 AM PT

  Rapid Onset of Response in Adult Dermatomyositis Patients Receiving Anti-interferon β (PF-06823859): Results of a Phase 2, Double-blind, Randomized, Placebo-Controlled Study
  

  Presenting Author: Rohit Aggarwal, MD, MS – University of Pittsburgh
• 9:40 AM – 9:45 AM PT

  Q&A
  
• 9:45 AM – 9:55 AM PT

  Frequency of Atherosclerotic Cardiovascular Disease Following a Diagnosis of Idiopathic Inflammatory Myopathy: Data from a Large National Registry
  

  Presenting Author: Astia Allenzara, MD – UNC
• 9:55 AM – 10:00 AM PT

  Q&A
  
• 10:00 AM – 10:10 AM PT

  Machine Learning Identifies New Sporadic Inclusion Body Myositis Endotypes Associated with Unique Autoantibody Profiles
  

  Presenting Author: Jing Yi Wei, BS, MSc – University of Toronto
• 10:10 AM – 10:15 AM PT

  Q&A
  
• 10:15 AM – 10:25 AM PT

  Validation of PROMIS in Adult and Pediatric Patients with Idiopathic Inflammatory Myopathies
  

  Presenting Author: Emma Austenfeld, MD, MPH – Medical College of Wisconsin
• 10:25 AM – 10:30 AM PT

  Q&A
  
• 10:30 AM – 10:40 AM PT

  High-intensity Resistance Training Improves Quality of Life, Muscle Endurance and Strength in Patients with Myositis
  

  Presenting Author: Kasper Yde Jensen, MSc – Copenhagen University Hospital - Rigshospitalet
• 10:40 AM – 10:45 AM PT

  Q&A